HB 546 – Maryland

Status: Inactive / Dead
Year Introduced: 2019
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb0546&stab=01&pid=billpage&tab=subject3&ys=2019RS

Altering the definition of “specialty drug” for purposes of certain provisions of law governing access to specialty drugs through certain pharmacies to include a drug designated as a limited distribution drug, a drug that is not available in an oral or self-administered formulation, or a drug that requires special handling above and beyond refrigeration or patient counseling; etc.


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found